Dr. Lauro Amezcua-Patiño is a Clinical and Administrative Adult and Adolescent Psychiatrist, with Board Certification in Adult Psychiatry, Forensic examiners, and Forensic Medicine. Married with 3 children, he has ben a resident of Arizona for 22 years.
Originally from Mexico, Bilingual and Bicultural, Dr. Amezcua-Patiño has been in clinical practice in the Metropolitan Phoenix Area for the last 20 years. He has extensive experience in the management and development of Behavioral Health services, for both adult and juvenile populations, including disadvantaged children, and children involved in the Juvenile Correctional system.
Dr. Amezcua-Patiño has been intimately involved in the development and management of Title XIX (Medicaid) services for both children (high percentage of foster care children) and adults, including but not limited to the development of case management systems, psychiatric clinical services, respite, and crisis services.
For the last 20 years, he has been involved in the development and management of not-for profit systems of care for the mentally ill, and disadvantaged youth and families, and continues to be involved in the management of these services, most recently as Consulting Medical Director of PreHab of Arizona, a not-for profit organization with a long track record of service to the Arizona Community, with particular expertise in Foster Care and Juvenile Corrections Children and Adolescents. Dr. Amezcua-Patiño received a Fellowship appointment in 2004 from the American Psychiatric Association.
He is frequently retained as an expert witness in Forensic Criminal Cases, including death penalty. He was formerly President of the Arizona Psychiatric Society for two terms, and its Director of Legislative Affairs for approximately twelve years. Dr. Amezcua-Patiño is currently the CEO and Medical Director of Metropolitan Neuro Behavioral Institute, in the Metropolitan Phoenix Area, and Medical Director of Aurora Behavioral Health Hospital in Tempe, Arizona.
He was a Consulting Medical Director of the Youth Development Institute, a not-for profit Residential Treatment Facility for seriously disturbed youth, most of them in foster care or under custody of the State of Arizona.Prior to February 2006 and for nine years, by appointment and reappointment by four different Governors of the State of Arizona, Dr. Amezcua-Patiño was been a member and Chairman of the State of Arizona, Psychiatric Security Review Board.
Dr. Amezcua-Patiño has participated in multiple positions of leadership the Public sector in the State of Arizona, including Member of the State of Arizona State Hospital Capital Construction Committee, the joint Legislative Committee on mental heath issues, and the Governor’s Behavioral Health Action Committee.
He has been a member of multiple speaker bureaus in the Pharmaceutical Industry, and is a frequent lecturer in issues related to Psychopharmacology, Mental Health disease concepts, Bio-Psycho-Social treatment, Case Management, Forensic issues, Cultural aspects of Psychiatric care, Domestic Violence, and Psychiatric Diagnosis.
Since he established residence in the State of Arizona in 1985, Dr. Amezcua-Patiño has been involved in activities in the Private Corporate sector, and is currently a Board Member of the Lilly Pharmaceuticals Zyprexa Advisory Board. He has been a consultant on children and adolescent issues for Janssen Pharmaceutica. He is a past Board Member of Ballet Arizona. Dr. Amezcua-Patiño was recently appointed to the Advisory Board of Republic Bank Arizona
Dr. Amezcua-Patiño has extensive experience in civil and criminal Psychiatric Forensic issues at the State and Federal level, consulting with Attorneys, Courts, Juvenile Corrections Commissioners, and Individuals, on issues ranging from child custody to death penalty, both in Arizona and other States, including but not limited to Texas, Colorado, New Mexico, Wisconsin and California
He has particular interest in issues related to the identification of bio-psycho-social (Genetics/prenatal trauma-experience-environment) factors that may impact and distort child development and attachment, specially in children that require Foster Care Placement, and developing methods of early identification to maximize preventive efforts.